v3.26.1
Unaudited Condensed Consolidated Interim Statements of Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Statement Line Items [Line Items]        
Revenue $ 0 $ 37 $ 0 $ 37
Research and development (2,334) (2,165) (4,631) (4,321)
General and administrative (1,512) (2,212) (3,034) (3,924)
Operating loss (3,846) (4,340) (7,665) (8,208)
Finance income 147 546 405 3,039
Finance expenses (234) (1,232) (519) (1,629)
Net loss before tax (3,933) (5,026) (7,779) (6,798)
Income tax benefit 204 195 420 387
Net loss for the period (3,729) (4,831) (7,359) (6,411)
Net loss attributable to shareholders of Evaxion A/S (3,729) (4,831) (7,359) (6,411)
Other comprehensive income that may be reclassified to profit or loss in subsequent periods:        
Exchange differences on translation of foreign operations 0 (45) 0 (78)
Other comprehensive income that will not be reclassified to profit or loss in subsequent periods:        
Exchange differences on currency translation to presentation currency (34) 714 (352) 597
Other comprehensive (loss)/ income for the period, net of tax (34) 669 (352) 519
Total comprehensive loss (3,763) (4,162) (7,711) (5,892)
Total comprehensive loss attributable to shareholders of Evaxion A/S $ (3,763) $ (4,162) $ (7,711) $ (5,892)
Loss per share – basic and diluted (in dollars per share) $ (0.01) $ (0.02) $ (0.02) $ (0.03)